Design, synthesis, and inhibition of α-glucosidase by novel L-phenylalanine-derived hydrazones: Kinetic, molecular docking, and dynamics studies
Özet
In this paper, a series of novel hydrazones derived from L-phenyl alanine were synthesized in four steps and employed to inhibit α-glucosidase through kinetic studies, molecular docking, and molecular dynamics analyses. Among the synthesized compounds, 8, 15, and 16 exhibited the strongest inhibitory effects, with IC50 values of 31.08 μM, 24.15 μM, and 19.47 μM, respectively, surpassing the standard inhibitor acarbose (79.63 μM). Molecular docking studies revealed robust interactions, with compound 16 achieving the highest MolDock score of −176.316. Molecular dynamics simulations were conducted to evaluate the binding affinity of compound 16 to the isomaltase enzyme from Saccharomyces cerevisiae (3A4A). The most favorable docking pose was subjected to further analysis through MD simulations under dynamic conditions. The MMGBSA analysis of the simulation cluster indicated a strong binding affinity of approximately −43.06 kcal/mol, highlighting the compound's potential for modulating α-glucosidase activity. These results underscore the potential of bromine and hydroxyl-substituted hydrazones to modulate isomaltase activity, with therapeutic implications for hyperglycemia and obesity management.
Anahtar Kelimeler
- Scopus
- 12
- WoS
- 12
- OpenAlex
- 16
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Kalay, Erbay | |
| dc.contributor.author | Adem, Şevki | |
| dc.contributor.author | Demir, Yeliz | |
| dc.contributor.author | Aslan, Osman Nuri | |
| dc.contributor.author | Şahin, Engin | |
| dc.contributor.author | Eyupoglu, Volkan | |
| dc.contributor.author | Rawat, Ravi | |
| dc.contributor.author | Çomaklı, Veysel | |
| dc.date.accessioned | 2026-10-29T19:08:26.387177705Z | |
| dc.date.available | 2026-10-29T19:08:26.387177705Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | In this paper, a series of novel hydrazones derived from L-phenyl alanine were synthesized in four steps and employed to inhibit α-glucosidase through kinetic studies, molecular docking, and molecular dynamics analyses. Among the synthesized compounds, 8, 15, and 16 exhibited the strongest inhibitory effects, with IC50 values of 31.08 μM, 24.15 μM, and 19.47 μM, respectively, surpassing the standard inhibitor acarbose (79.63 μM). Molecular docking studies revealed robust interactions, with compound 16 achieving the highest MolDock score of −176.316. Molecular dynamics simulations were conducted to evaluate the binding affinity of compound 16 to the isomaltase enzyme from Saccharomyces cerevisiae (3A4A). The most favorable docking pose was subjected to further analysis through MD simulations under dynamic conditions. The MMGBSA analysis of the simulation cluster indicated a strong binding affinity of approximately −43.06 kcal/mol, highlighting the compound's potential for modulating α-glucosidase activity. These results underscore the potential of bromine and hydroxyl-substituted hydrazones to modulate isomaltase activity, with therapeutic implications for hyperglycemia and obesity management. | |
| dc.identifier.articlenumber | 110368 | |
| dc.identifier.doi | 10.1016/j.abb.2025.110368 | |
| dc.identifier.eissn | 1096-0384 | |
| dc.identifier.issn | 0003-9861 | |
| dc.identifier.pmid | 40049269 | |
| dc.identifier.scopus | 2-s2.0-86000173226 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/bayburt/11478 | |
| dc.identifier.volume | 768 | |
| dc.identifier.wos | WOS:001444082500001 | |
| dc.language.iso | en | |
| dc.publisher | Academic Press Inc. | |
| dc.relation.ispartof | Archives of Biochemistry and Biophysics | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | And molecular dynamics | |
| dc.subject | Hydrazones | |
| dc.subject | Molecular docking | |
| dc.subject | α-Glucosidase | |
| dc.subject.classification | Biochemistry & Molecular Biology | |
| dc.subject.classification | Biophysics | |
| dc.subject.other | alpha-Glucosidases | |
| dc.subject.other | Drug Design | |
| dc.subject.other | Glycoside Hydrolase Inhibitors | |
| dc.subject.other | Hydrazones | |
| dc.subject.other | Kinetics | |
| dc.subject.other | Molecular Docking Simulation | |
| dc.subject.other | Molecular Dynamics Simulation | |
| dc.subject.other | Phenylalanine | |
| dc.subject.other | Saccharomyces cerevisiae | |
| dc.subject.other | 3,4,5 trimethoxy n [1 oxo 3 phenyl 1 [2 (3,4,5 trimethoxybenzylidene)hydrazineyl]propan 2 yl]benzamide | |
| dc.subject.other | 3,4,5 trimethoxy n [1 [2 (3 methoxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl]benzamide | |
| dc.subject.other | acarbose | |
| dc.subject.other | alpha glucosidase inhibitor | |
| dc.subject.other | hydrazone derivative | |
| dc.subject.other | n [1 [2 (2 bromo 5 hydroxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (2,3 dichlorobenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (2,3 dihydroxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (2,3 dimethoxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (2,4 dihydroxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (2,4 dimethoxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (2,5 dimethoxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (2,6 dichlorobenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (3 bromo 4 hydroxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (3 hydroxy 4 methoxybenzylidene)hydrazineyl] 1 oxo 3 phenyl propan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (3 hydroxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (3,4 dimethoxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (3,5 dibromo 2 hydroxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (4 fluorobenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (4 hydroxy 3 methoxybenzylidene)hydrazineyl] 1 oxo 3 phenyl propan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazineyl] 1 oxo 3 phenyl propan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | n [1 [2 (4 hydroxybenzylidene)hydrazineyl] 1 oxo 3 phenylpropan 2 yl] 3,4,5 trimethoxybenzamide | |
| dc.subject.other | phenylalanine derivative | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | alpha glucosidase | |
| dc.subject.other | glycosidase inhibitor | |
| dc.subject.other | Article | |
| dc.subject.other | binding affinity | |
| dc.subject.other | carbon nuclear magnetic resonance | |
| dc.subject.other | controlled study | |
| dc.subject.other | drug synthesis | |
| dc.subject.other | human | |
| dc.subject.other | human cell | |
| dc.subject.other | hyperglycemia | |
| dc.subject.other | molecular docking | |
| dc.subject.other | molecular dynamics | |
| dc.subject.other | obesity management | |
| dc.subject.other | proton nuclear magnetic resonance | |
| dc.subject.other | chemistry | |
| dc.subject.other | enzymology | |
| dc.subject.other | metabolism | |
| dc.subject.other | synthesis | |
| dc.title | Design, synthesis, and inhibition of α-glucosidase by novel L-phenylalanine-derived hydrazones: Kinetic, molecular docking, and dynamics studies | |
| dc.type | Article | |
| rdl.citation.openalex | 16 | |
| rdl.citation.scopus | 12 | |
| rdl.citation.wos | 12 | |
| rdl.department | Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Türkiye | |
| rdl.department | Faculty of Science, Chemistry Department, Cankiri Karatekin University, Cankiri, Türkiye | |
| rdl.department | Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, 75700, Ardahan, Türkiye | |
| rdl.department | Eastern Anatolia High Technology Application and Research Center, Atatürk University, 25240, Erzurum, Türkiye | |
| rdl.department | Faculty of Health Sciences, Department of Nutrition and Dietetics, Bayburt University, 69000, Bayburt, Türkiye | |
| rdl.department | School of Health Sciences & Technology, UPES University, Dehradun, India | |
| rdl.department | Department of Nutrition and Dietetics, İbrahim Çeçen University of Ağrı, Ağrı, Türkiye | |
| rdl.oa.status | closed | |
| rdl.oa.status | green | |
| rdl.oa.url | https://hdl.handle.net/20.500.12403/5970 | |
| rdl.scopus.quartile | Q1 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
